Talaris Therapeutics, Inc.
(NASDAQ GM: TALS)
Rigrodsky Law, P.A. is investigating Talaris Therapeutics, Inc. (“Talaris”) regarding possible breaches of fiduciary duties and other violations of law related to Talaris’s agreement to merge with Tourmaline Bio, Inc.